Please use this identifier to cite or link to this item:
http://dspace.iitrpr.ac.in:8080/xmlui/handle/123456789/108
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kaur, N. | |
dc.contributor.author | Kaur, K. | |
dc.contributor.author | Raj, T. | |
dc.contributor.author | Kaur, G. | |
dc.contributor.author | Singh, A. | |
dc.contributor.author | Aree, T. | |
dc.contributor.author | Park, S-J. | |
dc.contributor.author | Kim, T-J. | |
dc.contributor.author | Singh, N. | |
dc.contributor.author | Jange, D.O. | |
dc.date.accessioned | 2016-07-25T11:45:18Z | |
dc.date.available | 2016-07-25T11:45:18Z | |
dc.date.issued | 2016-07-25 | |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/108 | |
dc.description.abstract | A series of tricyclic dihydropyrimidine derivatives were synthesized using a one-pot, three-component Traube–Schwarz reaction in the presence of catalyst Zn(ClO4)2·6H2O. All the purified compounds were evaluated for their in vitro anticancer activity against three different cancer cell lines such as prostate cancer cells (PC3), lung cancer cells (NCI-H1299) and colon cancer cells (HCT116). In vitro DNA-intercalation ability of the compounds was investigated by UV–vis absorption spectroscopy, showing the insertion of compound into the DNA base pairs and a strong interaction with the DNA double helix. | en_US |
dc.language.iso | en_US | en_US |
dc.subject | Dihydropyrimidine | en_US |
dc.subject | One-pot | en_US |
dc.subject | Anticancer | en_US |
dc.subject | Traube–Schwarz reaction | en_US |
dc.subject | Multi-component reaction | en_US |
dc.subject | DNA binding | en_US |
dc.title | One-pot synthesis of tricyclic dihydropyrimidine derivatives and their biological evaluation | en_US |
dc.type | Article | en_US |
Appears in Collections: | Year-2015 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
1-s2.0-S0040402014016111-main(1).pdf | 663.69 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.